elegans embryos undergo morphogenetic movements that require the GTPase Rac1/CED-10 4 for epidermal enclosure, the sheet migration that leads to enclosure of the embryo by the six 5 rows of epidermal cells that form at the dorsal surface. To coordinate these migrations, the 6 GTPase Rac1/CED-10 activates the nucleation promoting factor WAVE/SCAR, which signals 7 to the branched actin nucleator Arp2/3 to initiate actin polarization. Mutating any component 8 in this pathway completely prevents the initiation of a sheet migration required for the 9 enclosure of the embryo by epidermal cells during morphogenesis in C. elegans (Fig. 1A ) 10
( Patel et al., 2008) . Our group was the first to show that three axonal guidance receptors, 11 UNC-40/DCC, SAX-3/Robo and VAB-1/Eph, are required during embryonic morphogenesis 12 to regulate the levels, localization and polarization of this actin nucleation pathway in 13 epidermal cells (Bernadskaya et al., 2012) . However, the molecules that connect the axonal 14 receptors to the regulation of GTPase activity during this migration are not known. 
16
Recent studies by several groups suggest that besides Rac1, the GTPases RHO-1 17 and CDC-42 are also contributing to a morphogenetic process of ventral enclosure (Ouellette 18 et al., 2016; Walck-Shannon et al., 2016; Wernike et al., 2016; Zilberman et al., 2017) . 19
However, the cytoskeletal consequences of altering RHO-1 or CDC-42 function during ventral 20 enclosure are poorly understood. Alisa Piekny and colleagues have shown that myosin is 21 required in the underlying neuroblasts to support epidermal cell migrations, suggesting 22 important roles for Rho in neuroblasts during embryonic morphogenesis (Fotopoulos et al., 23 2013; Wernike et al., 2016) . These studies raise the question of how Rho and myosin in the 24 underlying neuroblasts influence the behavior or the migrating epidermals cells. A model has 25 been proposed that myosin-based mechanical forces in neuroblasts influence constriction of 26 the overlying epidermal cells. An alternative role for the neuroblasts is to promote a chemical 27 cue that guides ventral enclosure, but the identity of this cue was not identified. 28
29
In C. elegans the GTPase RHO-1/Rho1 is needed throughout embryogenesis to 30 promote cytokinesis, and also contributes to a step in C. elegans morphogenesis that occurs 31 after the epidermis encloses the embryo, called embryonic elongation. During elongation the 32 epidermis constricts circumferentially to squeeze the embryo into a tubular worm. Embryonicmakes them harder to characterize. Removal of some GAPs that are known to result in 23 strong, striking changes in the cytoskeleton in tissue culture cells results in mild or minimal 24 effects when removed from developing organisms (Zaidel-Bar et al., 2010) . Several GAPs 25
are not essential for embryonic development, unless they are removed in the context of 26 reduced apical junctions (Walck-Shannon et al., 2016; Zilberman et al., 2017) . 27
28
The RhoGAP Myo9/Myosin IX is proposed to regulate multiple cellular functions 29 including adhesion, cell migration and immune function. Mammals have only two of these 30 myosins, Myo9a and Myo9b (Reviewed in Omelchenko 2012) . Loss of function mutations or 31 overexpression of these proteins has been linked to various cancers and immune defects. 32 Some studies support a role for Myo9B in human intestinal diseases like inflammatory bowel 33 disease and Crohn's disease (Li et al., 2016; Prager et al., 2014; Wang et al., 2016) . Thisconserved protein has a complex structure. Myo9 proteins have a C-terminal GAP domain 1 and most studies support that this GAP domain can attenuate Rho activity. Myo9 proteins 2 also have an N-terminal single headed processive myosin motor that can move the protein 3 towards the plus or barbed ends of F-actin fibers (Chandhoke and Mooseker, 2012; Hanley et 4 al., 2010; Hegan et al., 2016; Inoue et al., 2002; Liao et al., 2010; Omelchenko and Hall, 5 2012) . The role of other conserved motifs, including RA (Ras associated) and C1 domains, is 6 less well understood. The mouse knock out of Myo9A resulted in CNS defects (Abouhamed 7 et al., 2009) and kidney defects (Thelen et al., 2015) that may also involve changes in protein 8 trafficking, while the mouse Myo9b knockout resulted in altered morphology and motility of 9 immune cells (Hanley et al., 2010) and impaired intestinal barrier function (Hegan et al., 10 2016) . A pathway has been proposed in a human lung cancer model where SLIT/ROBO acts 11 to inhibit Myo9b, which releases RhoA. However, the exact reason why this double inhibitory 12 pathway is needed to regulate RhoA, and how misregulated RhoA promotes lung cancer is 13 unclear (Kong et al., 2015) . In metastatic prostate cancer cell lines Myo9b is elevated, while 14 knockdown of Myo9b results in altered NMY2A (non muscle myosin), and defective 15 migrations, further supporting a function in Rho attenuation (Makowska et al., 2015) . 16
17
C. elegans has a single Myo9 homolog, HUM-7, which has been characterized 18 extensively at the biochemical level, and was used to analyze how this single headed myosin 19 motor is able to move processively towards the plus end of actin fibers using an insertion in 20 the myosin head loop 2 (Liao et al., 2010) . However, the in vivo role of HUM-7 has not been 21
reported. C. elegans is thus an excellent in vivo system to probe the mechanisms behind the 22 complex phenotypes seen for mutations in Myo9/HUM-7. 23
24
We sought novel regulators of morphogenesis and identified the Myo9/Myosin 25 IX/HUM-7 protein. In this study we characterize the contribution of Myo9/HUM-7 to C. 26 elegans morphogenesis. We investigate which GTPases are affected by this RhoGAP, and 27 place hum-7 in a genetic pathway known to regulate actomyosin contractility. In addition, we 28 address how this proposed myosin IX motor affects F-actin levels, polarization and dynamics, 29 and how it compares to known Rho pathway mutants, including myosin phosphatase, mel-11. 30
We also investigate the contribution of Myo IX/HUM-7 to axonal guidance. Genetic epistasis 31 studies place this GAP downstream of two receptors, SAX-3/ROBO and VAB-1/EphB, known 32 to regulate F-actin during morphogenesis, to modulate Rho signaling. Targeted mutations 33 and GFP tagging using CRISPR allow us to test genetic regulation and tissue expression of 1 this RhoGAP. 2 3 4
Results -

5
Three axonal guidance receptors are upstream regulators of F-actin during morphogenesis 6 through their effects on WAVE/SCAR (Fig. 1A) (Bernadskaya et al., 2012) . To identify 7
proteins that might connect the axonal guidance receptors to WAVE/SCAR regulation, we 8 performed an RNAi screen to identify genes that enhance the low levels of embryonic 9 lethality (14%) caused by loss of one of the axonal guidance receptors, UNC-40. We 10 screened through a 2000-clone feeding RNAi library (Sieburth et al., 2005) which represents 11 about 10% of all C. elegans genes and identified several enhancers of unc-40 lethality using 12 the putative null allele unc-40(n324). RNAi depletion of HUM-7, an unconventional myosin 13 heavy chain protein, increased unc-40 embryonic lethality to 26%. hum-7 was thus a 14 candidate gene to act in parallel to unc-40 during morphogenesis. 15
16
HUM-7 functions in post-embryonic axonal guidance and genetically interacts with 17
WAVE/SCAR axonal guidance regulators in embryos and larvae. 18
To test if hum-7 affects other signals that regulate the WAVE-1 complex similarly to 19 how it affects unc-40, we fed hum-7 RNAi to animals missing other axonal guidance 20 receptors. One possible outcome might be enhancement of all the known signals that 21 organize F-actin in developing embryonic epidermis. However, while loss of HUM-7 22 significantly increased the embryonic lethality caused by loss of UNC-40, it had no significant 23 effect on the vab-1(dx31) null mutation, and it suppressed the embryonic lethality caused by 24 the sax-3(ky123) null mutation from 44% to 29% (Fig. 1B) . Therefore loss of hum-7 had 25 distinct effects on the three upstream signals that organize the cytoskeleton in developing 26
embryos. 27
One human homolog of HUM-7, Myo9A, is mutated in patients with defects in the 28 neuromuscular junction, leading to myasthenic syndrome (O'Connor et al., 2016) . To test if 29 HUM-7 had a post-embryonic developmental role, particularly in neurons, we characterized 30 the loss of HUM-7 on six mechanosensory neurons, including the AVM neuron, that are 31 easily visualized using the neuronal transgene mec-4::gfp (Yu et al., 2002) . In a wild type 32 background, the AVM neuron has a single round cell body and sends out one axonalprojection that travels ventrally to the nerve cord and then anteriorly (Fig. 1C) . RNAi depletion 1 of HUM-7 in the mec-4::gfp transgenic strain led to doubling of AVM ventral migration 2 defects. Therefore HUM-7 regulates development post-embryonically in the neurons known 3 to be affected by the loss of the axonal guidance receptors UNC-40, SAX-3 and VAB-1. 4
5
To determine if hum-7 and the axonal guidance receptor mutants interact genetically 6 during postembryonic development, we analyzed the effects of hum-7 RNAi on strains 7 containing null alleles of the axonal guidance mutants and the mec-4::gfp transgene. The 8 ventral migration defects caused by unc-40(n324) were enhanced from 50% to 62% by hum-9 7 RNAi. In contrast, sax-3(ky123) ventral migration defects were suppressed from 51% to 10 39% by hum-7 RNAi. There were no significant differences in ventral migration defects in 11 vab-1(dx31) mutants fed hum-7 RNAi (Fig. 1C,D) . Therefore, the post-embryonic genetic 12 interactions paralleled the embryonic genetic interactions. These results suggest the effects 13 described for HUM-7 function in the embryo are likely conserved postembryonically in other 14 tissues, including migrating axons. 15
16
HUM-7 functions in embryonic morphogenesis. 17
If HUM-7 is an important regulator of morphogenesis, it should have a phenotype on 18 its own. We depleted hum-7 via RNAi in a wild type (N2) background, which resulted in 6.5% 19 embryonic lethality. The hum-7(ok3054) mutation generated by the C. elegans Knockout 20 Consortium includes a 653 bp deletion including the 3' end of the myosin domain and two IQ 21 domains (binding sites for EF-hand proteins including regulatory myosin light chains and 22 calmodulin) (Bähler and Rhoads, 2002) (Fig. 2A) . We out-crossed this strain three times, and 23 detected 5.8% embryonic lethality. Since RNAi and the small deletion could be masking the 24 true loss of function phenotype, we generated an almost full length deletion using CRISPR, 25 hum-7(pj62), and observed similar phenotypes and slightly higher embryonic lethality of 26 9.5%. Approximately half of the dead embryos displayed a phenotype known as Gex (gut on 27 the exterior), which occurs 100% of the time when any gene in the WAVE complex is 28 knocked out. In a Gex embryo, the epidermal ventral migration step of morphogenesis fails 29 and as a result internal organs like the pharynx and intestine (gut) are exposed and the 30 embryo dies (Soto et al., 2002) . Other dead embryos displayed a 2-fold arrest phenotype 31 indicating a defect at the next morphogenesis step, elongation. All of these hum-7 32 phenotypes were observed in both hum-7 deletion mutants, and in the hum-7 RNAi embryos, 33 and in similar percentages ( Fig. 2A-D , Table 1 ). This is similar to putative null mutations inupstream regulators of F-actin, like unc-40, which are only 14% embryonic lethal. Therefore, 1 loss of hum-7 alone results in partially penetrant and strong morphogenesis phenotypes. 2
The hum-7 CRISPR alleles and Consortium deletion were used to further probe hum-7 3 genetic interactions with the axonal guidance genes. Testing the genetic interactions of hum-4 7 using the two deletions, ok3054 or pj62, gave similar results in combination with null 5 mutations in unc-40 (increased lethality), sax-3 (suppressed lethality) or vab-1 (no change) as 6 we saw with hum-7 RNAi ( Figure 2C ). This suggests RNAi results in strong loss of hum-7 7 function. To test the importance of the GAP domain, we used CRISPR to generate a point 8 mutation in the GAP of hum-7, pj63, and found different effects. This Arginine to Alanine (R 9 to A) mutation is predicted to perturb the GTPase activating function of RhoGAPs, resulted in 10 increased lethality compared to the deletions (30%), and more than additive lethality in 11 combination with unc-40 and vab-1. Unlike the deletion alleles, the pj63 GAP mutant could 12 not rescue sax-3 embryonic lethality ( Figure 2C ). This result suggests the hum-7 GAP 13 mutant behaves as a dominant negative (worse than the large deletion) and further supports 14 an interaction between hum-7 and sax-3. 15 16 HUM-7 functions as a GAP for Rho-1 and Cdc-42, but not for CED-10/Rac1. 17 HUM-7 has strong sequence homology with myosin IX/Myo9 proteins from a variety of 18 organisms, and includes the typical N-terminal myosin and C-terminal Rho GAP domains 19 (Abouhamed et al., 2009; Chandhoke and Mooseker, 2012; Hanley et al., 2010; Omelchenko 20 and Hall, 2012) . HUM-7 has greater than 30% overall protein identity with human Myosin 9a 21 and Myosin 9b (Fig. 1E) . While a C. elegans GAP that regulates the GTPase CED-10 during 22 cell corpse engulfment has been identified (Neukomm et al., 2011; Neukomm et al., 2014) , 23 this Rho GAP, SRGP-1, is completely dispensable for embryonic viability, and has limited 24 morphogenesis phenotypes as a single mutant (Zaidel-Bar et al., 2010 We hypothesized that if HUM-7 acts like a GAP for CED-10/Rac1, then loss of hum-7 30 would rescue partial loss of CED-10/Rac1. However, while the ced-10(n1993) hypomorphic 31 mutation resulted in 14% embryonic lethality, depletion of hum-7 via RNAi in the ced-32 10(n1993) hypomorphic allele increased embryonic lethality to 34% (Table 1, Fig. 2D) . 33
Experiments with a second hypomorphic allele, ced-10(n3246) similarly resulted in increased,not decreased embryonic lethality (Table 1) . Thus hum-7 and ced-10 appear to function in 1 parallel pathways. 2
3
To test if HUM-7 can function as a GAP for RHO-1/Rho, we used a temperature 4 sensitive allele of the known Rho GEF, . This allele has been well characterized 5 to partially knock down Rho signaling (Zonies et al., 2010) . At 20˚C, ect-2(ax751)/RHO-GEF 6 resulted in 42% embryonic lethality on control RNA, that dropped to 28% lethality in animals 7 also depleted of hum-7 via RNAi. Similarly, ect-2 RNAi leads to almost 100% dead embryos 8 but this drops to 84% dead embryos if RNAi is fed to hum-7 mutants (Fig. 2D GTPases we performed GST pull-down assays. Purified His-tagged GTPases in active (GTP 26 loaded) and inactive (GDP-loaded) form were individually tested for binding to the GAP 27 domain of HUM-7. The GAP domain of HUM-7 bound strongly to GTP-loaded RHO-1 and 28 CDC-42 and failed to bind GTP-loaded CED-10. No binding was observed between HUM-7 29 GAP and any of the GDP-loaded constructs tested for all three GTPases (Fig. 2E) . Therefore 30 biochemical studies suggested that HUM-7 could function as a GAP for RHO-1 and CDC-42 31 but not for CED-10. In short, HUM-7 behaves functionally, as well as molecularly, as a GAP 32 for RHO-1 and CDC-42, but not CED-10. 33 HUM-7 is expressed broadly with enhanced expression in muscles. 1
If HUM-7 is important for embryonic development, we expect it to be expressed in 2 embryos. We therefore created an N-terminally endogenously tagged allele of hum-7, pj72, 3 via CRISPR. CRISPR tagged gfp::hum-7 is broadly expressed in embryos at all stages, with 4 robust, enhanced expression in muscle, including the developing body wall muscles (Fig.  5   3A) . Staining gfp::hum-7 expressing embryos with monoclonal antibody 5.6 (Miller et al., 6 1983) which recognizes body wall muscles, confirmed the muscle enrichment in embryos and 7 larvae ( Figure 3A , indicated by enlarged boxed region). there is precedent for epidermal signal to appear striped due to impingement from muscle or 30 pharynx (Worm Atlas). Antibody staining with antibodies specific to body wall muscle support 31 that at least some of the striped signals are in muscle ( Figure 3A) . 32 hum-7 genetic interactions with the axonal guidance receptors led us to test if any of 1 them might be upstream regulators of gfp::hum-7. Loss of unc-40 or vab-1 had limited effects 2 on gfp::hum-7, but loss of sax-3 resulted in significantly elevated levels of gfp::hum-7 in all 3 tissues. Measuring the effect on the posterior bulb shows an increase of 100% (Fig. 3E) . 4 Therefore, the genetic and molecular interactions suggest sax-3 is upstream of hum-7 and 5 that SAX-3 signaling results in lower HUM-7 expression. 6 7
The phenotypes, genetic interactions and biochemical studies suggested hum-7 may 8 function in the regulation of Rho during morphogenesis. To address how this proposed RHO-9 1 GAP, HUM-7, contributes to morphogenesis, we analyzed its contribution an essential 10 event in embryonic development: ventral enclosure, which is driven by epidermal cell 11 migrations, and is mainly thought to be under Rac1/CED-10 control. 12 13 HUM-7 affects F-actin dynamics during the initial cell migrations required for epiboly. 14 Some of the embryonic phenotypes resulting from loss of HUM-7 resemble the Gex 15 phenotype seen when members of the WAVE/SCAR complex are mutated (Fig. 1A, 2B ). 16
Loss of WAVE/SCAR components during epidermal cell migration leads to defects in F-actin 17 levels, ventral F-actin enrichment and actin dynamics in the migrating epidermis 18 In wild-type embryos during the early stages of morphogenesis (250 minutes after the first 25 cell division), F-actin becomes enriched at the ventral edge of the leading cells of the 26 epidermis. As morphogenesis proceeds F-actin levels increase further and continue to be 27 ventrally enriched. When WAVE components are depleted via genetic mutation or RNAi 28 overall F-actin levels drop (Patel et al., 2008) . In hum-7 mutants or hum-7(RNAi) embryos the 29 overall levels of F-actin are higher than in wild type using the plin-26::vab-10 ABD strain, or 30 the plin26::Lifeact::mCherry strain ( Figure 4A -E). We conclude loss of hum-7 increases 31 epidermal F-actin levels. 32
In WAVE mutants F-actin fails to enrich ventrally in the migrating cells and therefore 33 fails to drive ventral enclosure (Bernadskaya et al., 2012; Patel et al., 2008) . However, inhum-7 mutants, F-actin is correctly enriched ventrally in the leading cells ( Fig. 4C 10+  1 embryos per genotype). Therefore, hum-7 does not appear to regulate ventral enrichment. 2
We next compared actin dynamics in hum-7 mutants, crossed into both F-actin 3 reporters. Previous work using the plin-26::vab-10 ABD transgene showed that wild type 4 ventral epidermal cells undergo frequent protrusions and retractions at the edge of the 5 leading cells, while protrusions and retractions in WAVE/SCAR mutants occurred less 6 frequently (Bernadskaya et al., 2012; Patel et al., 2008) . To assess the effects of hum-7 on 7 the actin protrusion dynamics, we imaged F-actin every two minutes from 240 minutes to 400 8 minutes after first cleavage. Wild-type embryos exhibited dynamic protrusions at the edge of 9 the leading cells, with an average of 0.45 protrusions per minute (n= at least 10 embryos per 10 phenotype). However in hum-7 mutants, protrusions were more frequent, with an average of 11 0.8 protrusions per minute (S1 Movie, S2 Movie). This result was also seen with the second 12 strain, plin26::Lifeact::mCherry, which showed an increase from 0.5 to 0.8 per minute (Fig.  13 4F,G). Therefore, the rate of actin protrusions is greater in hum-7 mutants than in wild type, 14 the opposite of the defect seen in WAVE mutants. 
HUM-7 regulates timing of epidermal morphogenesis. 27
Mutations in WAVE/SCAR, or in upstream regulators of WAVE/SCAR, including UNC-28 40/DCC/Netrin Receptor, SAX-3/Robo Receptor and VAB-1/Ephrin Receptor, lead to delayed 29 migrations (Bernadskaya et al., 2012) . We compared the timing of enclosure in hum-7 30 mutants and found that while a low percent of embryos arrest partway through enclosure, 31 embryos on average are not delayed, and some can enclose more quickly than wild type. 32
For example, in one set of experiments 1/7 embryos arrested, while 2/7 embryos enclosed 33 significantly faster than wild type. In Movies S1 and S2 the hum-7(ok3054) embryo in thecenter achieves ventral enclosure faster than wild type while the hum-7(ok3054) embryo on 1 the right arrests during enclosure. We saw similar results, faster migrations, in the other 2 hum-7 mutants, pj62 (20% faster) and pj63 (10% faster) when compared to wild type 3 embryos and timed from 240 minutes after first cleavage to ventral enclosure, by 300 min.). 4
Together, these results demonstrate a role for HUM-7 in the regulation of F-actin dynamics 5 that contribute to the correct initiation of epidermal cell migrations during epidermal 6 enclosure, and correct timing of morphogenetic events. 7 8 HUM-7 functions as a GAP upstream of RHO-1 to regulate embryonic morphogenesis. 9
The role of the GTPases Rho/RHO-1 and Cdc42/CDC-42 in the ventral enclosure step of 10 morphogenesis is only beginning to be described (Fotopoulos et al., 2013) . In contrast, the 11 role of RHO-1 in a later morphogenetic step, epidermal elongation, is exceedingly well 12 studied (Diogon et al., 2007; Gally et al., 2009; Martin et al., 2014; Piekny et al., 2003; Piekny 13 et al., 2000) . Since hum-7 behaved genetically and molecularly like a candidate GAP for 14 RHO-1 (and CDC-42), we investigated if hum-7 mutants have defects in Rho-dependent 15 processes, like elongation. As shown in If hum-7 is a GAP for RHO-1, loss of HUM-7 might suppress mutations that decrease 20
Rho-dependent contractility, like let-502/RHO-1 Kinase, and enhance mutations that increase 21
Rho-dependent contractility, like mel-11/Myosin Phosphatase. These genetic interactions 22 have been demonstrated for the RHO GAP rga-2 (Diogon et al., 2007) . The let-502 ts allele, 23 sb118ts, resulted in 75% or 98% lethality at 25ºC or 25.5ºC, respectively. However this 24 lethality dropped to 60% or 72%, respectively, when we crossed in hum-7(ok3054) ( Table 1  25 and Fig. 5A ). In a wild-type background, mel-11 RNAi resulted in 36% lethality and this 26 lethality was enhanced to 60% in a hum-7 background (Table 1, Fig. 5A ). These results 27 support that hum-7 may be a GAP for RHO-1. 28
The effects of Rho signaling on cell migration might occur through the activation of 29 actomyosin contractility under the control of non-muscle myosin, NMY-2 in the epidermis. 30
We crossed the nmy-2::gfp strain to Plin-26::Lifeact::mCherry to visualize the epidermis, and 31 detected nmy-2::gfp puncta in the epidermal focal plane ( Figure 5C ), as previously shown by 32
Wernike and colleagues (Wernike et al., 2016) . During ventral enclosure, myosin puncta are 33 (Fig. 5C ). We examined how loss of hum-7 affected nmy-2::gfp levels. Overall, all tissues of 1 the embryo showed brighter nmy-2::gfp puncta in hum-7 RNAi and mutant embryos. To 2 measure effects on ventral enclosure, we measured the robust nmy-2::gfp epidermal signal 3 as the pocket cells met at the midline. Plotting the maximum intensity showed an increase of 4 20% in hum-7 mutants relative to controls (Fig. 5B) . 5
We tested how two proposed upstream regulators of hum-7 affected nmy-2::gfp 6 levels during ventral pocket cell meeting. A null mutation in sax-3, ky123, led to a 20% 7 decrease in the pocket cell signal while a null mutation in vab-1, dx31, led to 20% increase 8 (Figure 5B,D) . These results suggest both SAX-3 and VAB-1 regulate actomyosin contractility 9 in the migrating epidermal cells. To test if hum-7 is required for these changes we removed 10 hum-7 via RNAi in each strain. In the vab-1(dx31); hum-7 RNAi strain the myosin levels are 11 somewhere in the middle, closer to wild type, which suggests the effects of VAB-1 on HUM-7 12 may be indirect. In contrast, the levels of nmy-2::gfp in the sax-3(ky123); hum-7(RNAi) strain 13 resembled the levels of hum-7(RNAi) (elevated) further supporting that SAX-3 acts through 14 HUM-7. The analysis of Rho GAPs has been complicated by their sheer number. Even in C. 22 elegans which has fewer GAPs than mammals, there are 23 proteins with GAP domains to 23 regulate the small number of small GTPases. Our analysis of one of these 23 GAP proteins 24 has revealed exciting connections between axonal guidance receptors, the known players in 25 RHO-1 signaling, and the movements of the epidermis during ventral enclosure. Our findings 26 support a requirement for RHO-1 attenuation by the previously uncharacterized RhoGAP, 27 HUM-7/Myosin 9. hum-7 mutants have low penetrance ventral enclosure defects, coupled 28 with highly penetrant increased actin dynamics, which suggests that increased actin 29 dynamics in epidermal protrusions interferes with the normal processes that accompany 30 cellular migration. It has been shown in single cell migration systems that down regulation of 31 actomyosin contractility is required to allow persistent migration in one direction (Theisen et 32 al., 2012) . A similar event may be occurring in the migration of single axons, as we show 33 here ( Fig. 1) that loss of HUM-7 alters neuronal migrations. One interpretation of our resultsis that in a sheet migration of the embryonic epidermis, increased actomyosin contractility 1 interferes with persistent migration. Therefore increased actin dynamics, in the context of an 2 embryo, reveals occasional faster migrations, but also failed migrations, likely due to lack of 3 persistence in the direction of the migration direction. 4
5
Axonal guidance receptors regulate the RHO-1 pathway 6 7
Our results suggest that HUM-7 plays an important role coordinating the response to 8 external polarity cues by modulating RHO-1 activity to permit the correct levels and dynamics 9 of actin required for proper cellular movements. HUM-7's role in embryonic morphogenesis 10 was discovered through a screen for enhancers of the partially penetrant morphogenesis 11 defects caused by loss of an axonal guidance receptor, UNC-40/DCC (Fig.1) . hum-7 showed 12 distinct genetic interactions with each of three axonal guidance pathway receptors. 13
Particularly intriguing was the rescue of embryonic lethality for sax-3(ky123) null animals, 14 from 44% to 29% when hum-7 is removed via RNAi or genetic mutations ( Figure 1B, 2C) . 15
Since HUM-7 is proposed to regulate the RHO-1 pathway, we tested if the axonal guidance 16 mutants affected embryonic non-muscle myosin, using the nmy-2::gfp CRISPR strain. The 17 interaction was particularly interesting for SAX-3/ROBO. Loss of SAX-3 alters NMY-2::GFP 18 levels, and this is epistatic to hum-7, suggesting sax-3 and hum-7 are in a pathway that 19 regulates NMY-2. The connection between SAX-3 and HUM-7 is further supported by the 20 fact that loss of sax-3 results in elevated expression of overall GFP::HUM-7 levels measured 21 using a CRISPR line (Fig. 3E) . Our results support that SAX-3 is a positive regulator of RHO-22 1 signaling during the migrations of epidermal enclosure, and that SAX-3 acts, at least in part, 23 through negative regulation of the RhoGAP HUM-7. Since loss of hum-7 does not fully 24 rescue loss of SAX-3, it is clear SAX-3 has other targets during ventral enclosure. 25
26
It is possible that VAB-1/EphrinB also regulates HUM-7, to regulate the RHO-1 pathway. 27
Overall vab-1 has opposite effects as sax-3 in combination with RHO-1 pathway mutants. 28
For example, loss of Rho Kinase/LET-502, which reduces RHO-1 signaling, results in 29 embryonic lethality that can be rescued by loss of hum-7 or vab-1, but not by loss of sax-3, 30 suggesting VAB-1 has an overall negative effect on RHO-1 signaling (Fig. 4B) . In support of 31 this, loss of vab-1 enhances loss of Myosin Phosphatase/MEL-11, just like loss of hum-7, and 32 similarly increased levels of nmy-2::gfp. However, the effects of VAB-1 on the RHO-1 33 pathway may not be directly through HUM-7. Loss of vab-1 did not significantly affect we uncover here, from SAX-3/ROBO to HUM-7/Myo9, to modulate RHO-1/Rho, has beenproposed to function in human lung cancer tissue culture cells. The altered timing of the 1 migrations in hum-7 mutant embryos suggests one consequence of misregulated Rho in the 2 absence of this RhoGAP is overactive Rho that leads to excess protrusions at the leading 3 edge, without a matching increase in retractions. This change may create various problems. 4
It is possible the protrusions are too stable, due to decreased turnover of Rho-GTPase. 5
While this may lead to occasional faster migrations, it may also make the cells less 6 responsive to their environment. For migrating epidermal cells, this could reduce detection of 7 tension in the underlying neuroblasts that are thought to help guide the migrations. The 8 defects in hum-7 mutants, therefore, may combine failure to properly transmit signals within 9 the epidermal cells, and also, failure to detect signals from cells in neighboring tissues. 10
Tissue specific rescue experiments of hum-7 to resolve this would be challenging, since the 11 overall lethality is so low. However, future experiments will need to address the tissue 12 specificity of the signals, and of HUM-7 function in receiving these signals, to address how 13 the epidermis and neuroblasts cooperate during this complex migration. 14 15 16 17
18
Materials and Methods
20
Strains:
21
The following strains were used in this study: His-tagged and purified using His-Bind resin (Novagen). The GST-tagged HUM-7 construct was 5 purified using Glutathione Sepharose 4B beads (GE Healthcare) based on manufacturers instructions.
6
For the pull-down assay, 30µg of purified GST-tagged proteins were incubated with 10µg His-tagged 7 proteins at 4˚C for two hours. Pull-downs were performed with GST beads, proteins were separated 8 on 12% acrylamide gels, and blots were probed with antibody to His (Millipore).
10
RNA interference:
11
All RNAi used in this study was administered by the feeding protocol as in (Bernadskaya et al., 2012) .
12
RNAi were constructed by cloning cDNA's of the genes into the L4440 vector and transforming them 13 into HT115 competent cells. Small overnight bacterial cultures were diluted 1:250 and grown until the 14 OD600 was close to 1. The culture was pelleted and resuspended in LB media containing 100 µg/ml
15
Ampicillin and 1mM IPTG.
17
Embryonic Lethality counts and imaging:
18 Synchronized L1 worms were plated on AMP/IPTG plates containing the appropriate RNAi bacteria.
19
Plates were cultured at 23˚C for three days. Temperature sensitive mutants like ect-2(ax751) were 20 cultured at three different temperatures, 15˚C, 20˚C and 25˚C. After the three-day incubation, 21 embryos were mounted on 3% agarose pads and lethality was counted.
23
Neuronal Migration Analysis:
24
For mec-4::gfp neuronal analysis, synchronized L1 worms were plated on AMP/IPTG plates 25 containing the appropriate RNAi bacteria and cultured for 2-3 days at 20˚C. L4440 empty vector was 26 used as the control RNAi. The effectiveness of hum-7 RNAi was monitored by counting the percent 27 embryonic lethality. After incubation, L4 worms were mounted unto 3% agarose pads with 10mM levamisole to prevent frequent movement and scored for phenotypes within 15 minutes of mounting.
1
The AVM mechanosensory neuron was checked for ventral migration defects. The table in Fig. 2B was performed using GraphPad Prism.
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